Pediatrix Medical Group, Inc. (NYSE:MD) Shares Bought by Principal Financial Group Inc.

Principal Financial Group Inc. increased its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 7.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 551,924 shares of the company's stock after buying an additional 38,306 shares during the quarter. Principal Financial Group Inc. owned 0.64% of Pediatrix Medical Group worth $7,241,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. Quest Partners LLC boosted its position in Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company's stock valued at $35,000 after buying an additional 622 shares during the last quarter. Quarry LP lifted its stake in Pediatrix Medical Group by 54.1% during the 3rd quarter. Quarry LP now owns 4,735 shares of the company's stock valued at $55,000 after acquiring an additional 1,662 shares during the period. FMR LLC boosted its holdings in shares of Pediatrix Medical Group by 220.6% in the 3rd quarter. FMR LLC now owns 9,841 shares of the company's stock valued at $114,000 after acquiring an additional 6,771 shares during the last quarter. Quantinno Capital Management LP acquired a new stake in shares of Pediatrix Medical Group in the third quarter worth $138,000. Finally, SG Americas Securities LLC purchased a new position in shares of Pediatrix Medical Group during the fourth quarter worth $171,000. 97.71% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Macquarie initiated coverage on Pediatrix Medical Group in a research note on Monday, December 16th. They set an "outperform" rating and a $18.00 price objective for the company. StockNews.com raised shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research note on Wednesday, January 22nd. Truist Financial boosted their target price on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a "hold" rating in a research note on Friday, February 21st. Mizuho lifted their price objective on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a "neutral" rating in a report on Tuesday, November 19th. Finally, Jefferies Financial Group increased their target price on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a "buy" rating in a research note on Tuesday, November 5th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, Pediatrix Medical Group has a consensus rating of "Hold" and an average target price of $17.08.

Pediatrix Medical Group Stock Down 2.1 %

Shares of Pediatrix Medical Group stock traded down $0.31 on Monday, reaching $14.46. 877,480 shares of the company were exchanged, compared to its average volume of 601,682. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The stock's 50 day moving average price is $13.99 and its 200-day moving average price is $13.19. The company has a market cap of $1.24 billion, a P/E ratio of -12.05, a price-to-earnings-growth ratio of 1.74 and a beta of 1.57. Pediatrix Medical Group, Inc. has a 1-year low of $6.62 and a 1-year high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, beating analysts' consensus estimates of $0.37 by $0.12. The company had revenue of $502.36 million during the quarter, compared to analysts' expectations of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. As a group, equities analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.